サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1262931

ゲノム編集/ゲノム工学の世界市場レポート2023年

Genome Editing/Genome Engineering Global Market Report 2023
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.25円
ゲノム編集/ゲノム工学の世界市場レポート2023年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ゲノム編集またはゲノム工学の世界市場は、2022年の61億1,000万米ドルから2023年には72億米ドルへと、CAGR17.8％で成長すると予測されています。ロシアとウクライナの戦争は、少なくとも短期的には、COVID-19パンデミックからの世界経済の回復の可能性を混乱させました。この2国間の戦争は、複数の国に対する経済制裁、商品価格の高騰、サプライチェーンの混乱につながり、商品やサービス全体にインフレを引き起こし、世界中の多くの市場に影響を与えています。ゲノム編集またはゲノム工学市場は、CAGR18.5%で2027年に142億2,000万米ドルに成長すると予想されています。

2022年のゲノム編集/ゲノム工学市場では、北米が最大の地域となりました。アジア太平洋は、予測期間中に最も急速に成長する地域となる見込みです。ジェノン・エディット／ゲノム・エンジニアリング市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

がんやその他の遺伝性疾患の有病率の上昇は、今後ゲノム編集/ゲノム工学市場の成長を促進すると予想されます。がんは、身体の一部の細胞が制御不能に成長し、身体の他の部位に広がる状態です。ゲノム編集は、がん治療用の免疫細胞やoncolytic virusを迅速に工学的に作り出すことができます。例えば、2022年2月、スイスに本部を置く国連の保健機関である世界保健機関（WHO）が発表した論文によると、2020年の死亡原因の約6人に1人にあたる約1000万人ががんで死亡し、世界の死因の第1位になっています。さらに、2022年6月、米国を拠点とする国の公衆衛生機関であるCDC（Centers for Disease Control and Prevention）が発表した報告書によると、2019年に米国で新たに報告された侵襲性がんの症例は、女性で86万3830人、男性で88万905人、計1752万3735件でした。すべてのがんの発生率は、一般人口10万人あたり439人でした。したがって、がんやその他の遺伝性疾患の有病率の上昇が、ゲノム編集／ゲノムエンジニアリング市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 ゲノム編集/ゲノム工学市場の特徴

第3章 ゲノム編集/ゲノム工学の市場動向と戦略

第4章 ゲノム編集/ゲノム工学市場- マクロ経済シナリオ

  • COVID-19別ゲノム編集/ゲノム工学市場への影響
  • ウクライナとロシアの戦争がゲノム編集/ゲノム工学市場に与える影響
  • ゲノム編集/ゲノム工学市場に対する高インフレの影響

第5章 ゲノム編集/ゲノム工学の市場規模と成長

  • 世界のゲノム編集/ゲノム工学市場の実績、2017-2022年
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のゲノム編集/ゲノム工学市場の予測、2022-2027F、2032F
    • 市場の促進要因
    • 市場の抑制要因

第6章 ゲノム編集/ゲノム工学市場セグメンテーション

  • 世界のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 試薬と消耗品
  • ソフトウェアとシステム
  • サービス
  • 世界のゲノム編集/ゲノム工学市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • クラスター化された規則的に間隔を空けた短い回文反復（CRISPR）
  • 転写活性化因子様エフェクターヌクレアーゼ（TALEN）
  • ジンクフィンガーヌクレアーゼ（ZFN）
  • アンチセンス
  • その他の技術
  • 世界のゲノム編集/ゲノム工学市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 細胞株工学
  • 遺伝子工学
  • 診断アプリケーション
  • 創薬と開発
  • その他のアプリケーション
  • 世界ゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • バイオテクノロジー企業
  • 製薬会社
  • 学術および政府の調査機関

第7章 ゲノム編集/ゲノム工学市場の地域および国の分析

  • 世界ゲノム編集/ゲノム工学市場、地域別、実績と予測、2017-2022、2022-2027F、2032F
  • 世界のゲノム編集/ゲノム工学市場、国別、実績と予測、2017-2022、2022-2027F、2032F

第8章 アジア太平洋のゲノム編集/ゲノム工学市場

  • アジア太平洋のゲノム編集/ゲノム工学市場概要
  • 地域情報, COVID-19の影響,市場情報,背景情報,政府のイニシアチブ,規制,規制機関,主要団体,課税される税,法人税構造,投資,主要企業
  • アジア太平洋のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アジア太平洋のゲノム編集/ゲノム工学市場、エンドユーザー別のセグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第9章 中国のゲノム編集/ゲノム工学市場

  • 中国ゲノム編集/ゲノム工学市場概要
  • 中国のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中国のゲノム編集/ゲノム工学市場、エンドユーザー別のセグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第10章 インドのゲノム編集/ゲノム工学市場

  • インドのゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドのゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第11章 日本のゲノム編集/ゲノム工学市場

  • 日本のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 日本のゲノム編集/ゲノム工学市場、エンドユーザー別のセグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第12章 オーストラリアのゲノム編集/ゲノム工学市場

  • オーストラリアのゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • オーストラリアのゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第13章 インドネシアのゲノム編集/ゲノム工学市場

  • インドネシアのゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドネシアのゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第14章 韓国のゲノム編集/ゲノム工学市場

  • 韓国のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 韓国のゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第15章 西欧のゲノム編集/ゲノム工学市場

  • 西欧のゲノム編集/ゲノム工学市場概要
  • 西欧のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 西欧のゲノム編集/ゲノム工学市場、エンドユーザー別のセグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第16章 英国のゲノム編集/ゲノム工学市場

  • 英国のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 英国のゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第17章 ドイツのゲノム編集/ゲノム工学市場

  • ドイツのゲノム編集/ゲノム工学市場、製品およびサービス別のセグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ドイツのゲノム編集/ゲノム工学市場、エンドユーザー別のセグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第18章 フランスゲノム編集/ゲノム工学市場

  • フランスのゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • フランスのゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第19章 東欧のゲノム編集/ゲノム工学市場

  • 東欧ゲノム編集/ゲノム工学市場概要
  • 東欧のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 東欧のゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第20章 ロシアのゲノム編集/ゲノム工学市場

  • ロシアのゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ロシアのゲノム編集/ゲノム工学市場、エンドユーザー別のセグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第21章 北米のゲノム編集/ゲノム工学市場

  • 北米ゲノム編集/ゲノム工学市場概要
  • 北米のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 北米ゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第22章 米国のゲノム編集/ゲノム工学市場

  • 米国ゲノム編集/ゲノム工学市場概要
  • 米国のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 米国ゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第23章 南米のゲノム編集/ゲノム工学市場

  • 南米ゲノム編集/ゲノム工学市場概要
  • 南米のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 南米のゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第24章 ブラジルのゲノム編集/ゲノム工学市場

  • ブラジルのゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ブラジルのゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第25章 中東のゲノム編集/ゲノム工学市場

  • 中東ゲノム編集/ゲノム工学市場概要
  • 中東のゲノム編集/ゲノム工学市場、製品とサービス別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中東のゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第26章 アフリカのゲノム編集/ゲノム工学市場

  • アフリカのゲノム編集/ゲノム工学市場概要
  • アフリカゲノム編集/ゲノム工学市場、製品およびサービス別のセグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アフリカゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第27章 ゲノム編集/ゲノム工学市場の競合情勢と企業プロファイル

  • ゲノム編集/ゲノム工学市場の競合情勢
  • ゲノム編集/ゲノム工学市場企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Merck Group
    • Genscript Biotech Corp
    • Sangamo Therapeutics Inc.
    • Lonza Group AG

第28章 ゲノム編集/ゲノム工学市場における主要な合併と買収

第29章 ゲノム編集/ゲノム工学市場の将来展望と可能性分析

第30章 付録

目次
Product Code: r5409

“Genome Editing/Genome Engineering Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genome editing/genome engineering market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genome editing/genome engineering? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The genome editing/genome engineering market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product And Service: Reagents And Consumables; Software And systems; Services
  • 2) By Technology: CRISPR; TALEN; ZFN; Antisense; Other Technologies
  • 3) By Application: Cell Line Engineering; Genetic Engineering; Diagnostic Applications; Drug Discovery And Development; Other Applications
  • 4) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Government Research Institutes
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck Group; Genscript Biotech Corp; Sangamo Therapeutics Inc.; Lonza Group AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the genome editing/genome engineering market are: Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., and Cellectis S.A.

The global genome editing or genome engineering market is expected to grow from $6.11 billion in 2022 to $7.20 billion in 2023 at a compound annual growth rate (CAGR) of 17.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The genome editing or genome engineering market is expected to grow to $14.22 billion in 2027 at a CAGR of 18.5%.

The genome editing market includes revenues earned by entities by cell line engineering, animal genetic engineering, plant genetic engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Genome editing is a technique that enables scientists to alter the DNA of numerous organisms, including plants, bacteria, and animals. With the help of genome editing technologies, researchers would alter DNA, changing physical characteristics like eye colour and the risk of contracting diseases. Genome editing is used in animal models and cells in research labs to understand diseases.

North America was the largest region in the genone editing/genome engineering market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genone editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main type of product and services of genome editing/genome engineering are reagents and consumables, software and systems, services. The reagents and consumables are used at specific locations in the genome of a target organism to cause breaks, repairs, or mismatches involving endogenous mechanisms to cause specific changes in DNA sequence. Consumables are items that can be used up until they run out and then need to be disposed of. A compound or substance that can speed up a reaction is called a reagent. The technology used are Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nucleases (ZFN), antisense, and other technologies, which are applied in cell line engineering, genetic engineering, diagnostic applications, drug discovery and development, and other applications, that are used by biotechnology companies, pharmaceutical companies, academic and government research institutes.

The rise in the prevalence of cancer and other genetic disorders is expected to propel the growth of the genome editing/genome engineering market going forward. Cancer is a condition wherein a few of the body's cells grow out of control and spread to other body regions. Genome editing can quickly engineer immune cells and oncolytic viruses for cancer therapeutic applications. For instance, in February 2022, according to an article published by World Health Organization (WHO), a Switzerland-based United Nations health agency, nearly 10 million deaths, or nearly one in six deaths, were caused by cancer in 2020, making it the leading cause of death worldwide. Further, in June 2022, according to a report published by the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, 1,752,735 new cases of invasive cancer in total, 863,830 in women and 888,905 in men were reported in the US in 2019. The incidence rate for all cancers was 439 per 100,000 people in the general population. Therefore, the rise in the prevalence of cancer and other genetic disorders is driving the growth of the genome editing/ genome engineering market.

Technological advancements in gene editing are a key trend gaining popularity in the genome editing or genome engineering market. Major companies operating in the genome editing/genome engineering market is concentrating on creating innovative technology solutions to improve their position. For instance, in May 2022, Kyoto University and Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a Spain-based research university focused on evolutionary biology, researchers unveiled a quick and effective method for editing genes in insects. Direct parental CRISPR (DIPA-CRISPR), a simple and effective method, involves injecting materials into developing eggs in female adults rather than embryos. The novel technique enables researchers to avoid microinjecting CRISPR material into insect embryos.

In March 2020, Zymergen, a US-based biotechnology company, acquired enEvolv, Inc. for an undisclosed amount. With the acquisition, Zymergen launched new products and was estimated to increase by 20%, speeding up the pace and scope of bio-manufacturing. enEvolv, Inc. is a US-based genome engineering company.

The countries covered in the genome editing/genome engineering market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The genome editing/genome engineering market research report is one of a series of new reports from The Business Research Company that provides genome editing/genome engineering market statistics, including genome editing/genome engineering industry global market size, regional shares, competitors with a genome editing/genome engineering market share, detailed genome editing/genome engineering market segments, market trends and opportunities, and any further data you may need to thrive in the genome editing/genome engineering industry. This genome editing/genome engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Genome Editing/Genome Engineering Market Characteristics

3. Genome Editing/Genome Engineering Market Trends And Strategies

4. Genome Editing/Genome Engineering Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Genome Editing/Genome Engineering Market
  • 4.2. Ukraine-Russia War Impact On Genome Editing/Genome Engineering Market
  • 4.3. Impact Of High Inflation On Genome Editing/Genome Engineering Market

5. Genome Editing/Genome Engineering Market Size And Growth

  • 5.1. Global Genome Editing/Genome Engineering Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Genome Editing/Genome Engineering Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Genome Editing/Genome Engineering Market Segmentation

  • 6.1. Global Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Reagents And Consumables
  • Software And Systems
  • Services
  • 6.2. Global Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
  • Transcription Activator-Like Effector Nuclease (TALEN)
  • Zinc Finger Nucleases (ZFN)
  • Antisense
  • Other Technologies
  • 6.3. Global Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostic Applications
  • Drug Discovery And Development
  • Other Applications
  • 6.4. Global Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Academic And Government Research Institutes

7. Genome Editing/Genome Engineering Market Regional And Country Analysis

  • 7.1. Global Genome Editing/Genome Engineering Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Genome Editing/Genome Engineering Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Genome Editing/Genome Engineering Market

  • 8.1. Asia-Pacific Genome Editing/Genome Engineering Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Genome Editing/Genome Engineering Market

  • 9.1. China Genome Editing/Genome Engineering Market Overview
  • 9.2. China Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Genome Editing/Genome Engineering Market

  • 10.1. India Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Genome Editing/Genome Engineering Market

  • 11.1. Japan Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Genome Editing/Genome Engineering Market

  • 12.1. Australia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Genome Editing/Genome Engineering Market

  • 13.1. Indonesia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Genome Editing/Genome Engineering Market

  • 14.1. South Korea Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Genome Editing/Genome Engineering Market

  • 15.1. Western Europe Genome Editing/Genome Engineering Market Overview
  • 15.2. Western Europe Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Genome Editing/Genome Engineering Market

  • 16.1. UK Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Genome Editing/Genome Engineering Market

  • 17.1. Germany Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Genome Editing/Genome Engineering Market

  • 18.1. France Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Genome Editing/Genome Engineering Market

  • 19.1. Eastern Europe Genome Editing/Genome Engineering Market Overview
  • 19.2. Eastern Europe Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Genome Editing/Genome Engineering Market

  • 20.1. Russia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Genome Editing/Genome Engineering Market

  • 21.1. North America Genome Editing/Genome Engineering Market Overview
  • 21.2. North America Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Genome Editing/Genome Engineering Market

  • 22.1. USA Genome Editing/Genome Engineering Market Overview
  • 22.2. USA Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Genome Editing/Genome Engineering Market

  • 23.1. South America Genome Editing/Genome Engineering Market Overview
  • 23.2. South America Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Genome Editing/Genome Engineering Market

  • 24.1. Brazil Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Genome Editing/Genome Engineering Market

  • 25.1. Middle East Genome Editing/Genome Engineering Market Overview
  • 25.2. Middle East Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Genome Editing/Genome Engineering Market

  • 26.1. Africa Genome Editing/Genome Engineering Market Overview
  • 26.2. Africa Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Genome Editing/Genome Engineering Market Competitive Landscape And Company Profiles

  • 27.1. Genome Editing/Genome Engineering Market Competitive Landscape
  • 27.2. Genome Editing/Genome Engineering Market Company Profiles
    • 27.2.1. Thermo Fisher Scientific Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Merck Group
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Genscript Biotech Corp
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Sangamo Therapeutics Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Lonza Group AG
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Genome Editing/Genome Engineering Market

29. Genome Editing/Genome Engineering Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer